Brainstorm Cell Therapeutics reported $7.85M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US 7.04M 8.86M
Biogen BIIB:US $ 11872.5M 630.2M
Brainstorm Cell Therapeutics BCLI:US $ 7.85M 6.64M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Cytokinetics CYTK:US $ 111.41M 4.85M
Gilead Sciences GILD:US $ 20215M 288M
Halozyme Therapeutics HALO:US $ 293.17M 32.92M
Idera Pharmaceuticals IDRA:US $ 21.13M 4.71M